ACHIEVEMENT OF THE TARGET GOAL FOR LDL-CHOLESTEROL BY ROSUVASTATIN IN JAPANESE HYPERCHOLESTEROLEMIC SUBJECTS

被引：0
|
作者：
Nakano, S. [1 ,2 ]
Yoshino, G. [2 ]
机构：
[1] Sagamihara Chuo Hosp, Kanagawa, Japan
[2] Toho Univ, Sch Med, Tokyo, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70874-6
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
MS373
引用
收藏
页码：185 / 185
页数：1
相关论文
共 50 条
  • [41] Many Risk Patients are not in the LDL Cholesterol Target Range: The Goal is to achieve the Goal
    Leodolter, Hugo
    JOURNAL FUR HYPERTONIE, 2012, 16 (04): : 42 - 42
  • [42] ATTAINMENT OF LDL-CHOLESTEROL GOALS IS SUBOPTIMAL WITH ROSUVASTATIN MONOTHERAPY IN US PATIENTS AT HIGH CARDIOVASCULAR RISK
    Marrett, E.
    Zhang, Q.
    Zhao, C.
    Ramey, D.
    Neff, D. R.
    Tershakovec, A. M.
    VALUE IN HEALTH, 2013, 16 (03) : A274 - A274
  • [43] Single LDL-Cholesterol Apheresis Treatment Does Not Improve Vascular Endothelial Function in Hypercholesterolemic Patients
    Ballard, Kevin
    Taylor, Beth
    Beam, Jo Ellen
    Mah, Eunice
    Guo, Yi
    Bruno, Richard
    Polk, Donna
    Thompson, Paul
    FASEB JOURNAL, 2015, 29
  • [44] EFFECTS OF PSYLLIUM HYDROPHILIC MUCILLOID ON LDL-CHOLESTEROL AND BILE-ACID SYNTHESIS IN HYPERCHOLESTEROLEMIC MEN
    EVERSON, GT
    DAGGY, BP
    MCKINLEY, C
    STORY, JA
    JOURNAL OF LIPID RESEARCH, 1992, 33 (08) : 1183 - 1192
  • [45] Status of non-HDL-cholesterol and LDL-cholesterol among subjects with and without metabolic syndrome
    Khan, Sikandar Hayat
    Asif, Naveed
    Ijaz, Aamir
    Manzoor, Syed Mohsin
    Niazi, Najumusaquib Khan
    Fazal, Nadeem
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (04) : 554 - 558
  • [46] LDL-cholesterol goal attainment among patients treated with lipid lowering drugs in Spain
    García-Ruiz, FJ
    Marín, A
    Pérez-Jimenez, F
    Pintó, X
    Nocea, G
    Casado, MA
    Erbey, J
    Alemao, EA
    Yi, DD
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 119 - 119
  • [47] THE EFFECTS OF INDIGESTIBLE DEXTRIN AND PHYTOSTEROL ON SERUM CHOLESTEROL LDL LEVEL OF HYPERCHOLESTEROLEMIC SUBJECTS
    Bardosono, Saptawati
    Then, Anna H.
    Harahap, Indriati P.
    ANNALS OF NUTRITION AND METABOLISM, 2009, 55 : 134 - 135
  • [48] STATIN TREATMENT AND ENDOTHELIAL FUNCTION IN HYPERTENSIVE SUBJECTS WITH NORMAL LDL-CHOLESTEROL LEVELS
    Schneider, M.
    Schmidt, B.
    John, S.
    Schmieder, R.
    JOURNAL OF HYPERTENSION, 2010, 28 : E121 - E122
  • [49] NON-ACHIEVEMENT OF LDL-CHOLESTEROL GOALS FROM THE RUSSIAN FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY
    Bliznyuk, S.
    Chubykina, U.
    Rozhkova, T.
    Ezhov, M.
    ATHEROSCLEROSIS, 2019, 287 : E220 - E220
  • [50] INCLISIRAN REDUCES LDL-CHOLESTEROL INDEPENDENT OF GENOTYPE IN SUBJECTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA
    Raal, F. J.
    Kallend, D.
    Ray, K. K.
    Turner, T. A.
    Koenig, W.
    Wright, R. S.
    Wijngaard, P. L.
    Curcio, D.
    Jaros, M. J.
    Leiter, L. A.
    Landmesser, U.
    Kastelein, J. J.
    ATHEROSCLEROSIS, 2020, 315 : E7 - E8
12345